These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36945423)

  • 21. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
    AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
    Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.
    Jahn B; Sroczynski G; Bicher M; Rippinger C; Mühlberger N; Santamaria J; Urach C; Schomaker M; Stojkov I; Schmid D; Weiss G; Wiedermann U; Redlberger-Fritz M; Druml C; Kretzschmar M; Paulke-Korinek M; Ostermann H; Czasch C; Endel G; Bock W; Popper N; Siebert U
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33925650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Vaccination Strategies to Compare Efficient and Equitable Vaccine Allocation by Race and Ethnicity Across Time.
    Kipnis P; Soltesz L; Escobar GJ; Myers L; Liu VX
    JAMA Health Forum; 2021 Aug; 2(8):e212095. PubMed ID: 35977198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing Different COVID-19 Vaccination Strategies Using an Agent-Based Modeling Approach.
    Trad F; El Falou S
    SN Comput Sci; 2022; 3(4):307. PubMed ID: 35637643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study.
    Imai N; Rawson T; Knock ES; Sonabend R; Elmaci Y; Perez-Guzman PN; Whittles LK; Kanapram DT; Gaythorpe KAM; Hinsley W; Djaafara BA; Wang H; Fraser K; FitzJohn RG; Hogan AB; Doohan P; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet Public Health; 2023 Mar; 8(3):e174-e183. PubMed ID: 36774945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing Vaccination Prioritization Strategies for COVID-19 in South Africa Based on Age-Specific Compartment Model.
    Zuo C; Meng Z; Zhu F; Zheng Y; Ling Y
    Front Public Health; 2022; 10():876551. PubMed ID: 35784231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice.
    Kim E; Khan MS; Ferrari A; Huang S; Sammartino JC; Percivalle E; Kenniston TW; Cassaniti I; Baldanti F; Gambotto A
    Microbiol Spectr; 2023 Jun; 11(3):e0436322. PubMed ID: 37162333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
    Watson LM
    N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study.
    Savinkina A; Bilinski A; Fitzpatrick M; Paltiel AD; Rizvi Z; Salomon J; Thornhill T; Gonsalves G
    BMJ Open; 2022 Sep; 12(9):e061752. PubMed ID: 36100306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.
    Ferreira LS; de Almeida GB; Borges ME; Simon LM; Poloni S; Bagattini ÂM; da Rosa MQM; Diniz Filho JAF; Kuchenbecker RS; Camey SA; Kraenkel RA; Coutinho RM; Toscano CM
    Vaccine; 2022 Nov; 40(46):6616-6624. PubMed ID: 36210250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries.
    Obeng-Kusi M; Habila MA; Roe DJ; Erstad B; Abraham I
    J Med Econ; 2021 Nov; 24(sup1):1-13. PubMed ID: 34866541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study.
    Shoukat A; Vilches TN; Moghadas SM; Sah P; Schneider EC; Shaff J; Ternier A; Chokshi DA; Galvani AP
    Lancet Reg Health Am; 2022 Jan; 5():100085. PubMed ID: 34746912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
    Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
    Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
    Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
    BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi.
    Mseka UL; Mandolo J; Nyoni K; Divala O; Kambalame D; Mapemba D; Kamzati M; Chibwe I; Henrion MYR; Manda K; Thindwa D; Mvula M; Odala B; Kamng'ona R; Dzinza N; Jere KC; Feasey N; Ho A; Amoah AS; Gordon M; Swarthout TD; Crampin A; Heyderman RS; Kagoli M; Chitsa-Banda E; Mitambo C; Phuka J; Chilima B; Kasambara W; Jambo KC; Chauma-Mwale A
    EClinicalMedicine; 2023 Feb; 56():101800. PubMed ID: 36600885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities and effectiveness of COVID-19 vaccine policies in three representative European countries.
    Xie W; Shi L; Liu M; Yang J; Ma M; Sun G
    Int J Equity Health; 2024 Jan; 23(1):16. PubMed ID: 38287322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.